SA. A stem cell marker-expressing subset of enteroendocrine cells resides at the crypt base in the small intestine.
THE ENTEROENDOCRINE CELLS, which comprise ϳ1% of epithelial cells in the gastrointestinal system, represent the largest population of hormone-producing cells in the body (24) . The enteroendocrine cells share a common lineage with other principle nonendocrine cells in the intestine and originate from primitive intestinal stem cells located in the intestinal crypts. The present model of intestinal cell differentiation suggests that the intestinal stem cells constitute two complementary populations of stem cells, a self-renewing stem cell population and a quiescent stem cell population, presumably to maintain high turnover of all four distinct epithelial cell types (19) . The self-renewing stem cells highly express leucine-rich repeatcontaining G protein-coupled receptor 5 (Lgr5) and reside between Paneth cells at the crypt base, where Wnt signaling is active (2) , whereas quiescent stem cells express Bmi1 and reside at the position ϩ4 (23) . Thus the lineage-specific precursor cells are thought to differentiate immediately from the self-renewing Lgr5ϩ cells. As seen in immune or nervous system, the lineage fate decision is made through the Notch signaling pathway (10) . Notch signaling activates the promoters of the hairy enhancer of split (HES) transcription repressor that normally inhibits expression of proendocrine basic helixloop-helix (bHLH) transcription factors. The inactive state of Notch signaling allows cells to express proendocrine bHLH factors Math 1 and neurogenin 3 (Ngn3) and differentiate into endocrine cell lineage-specific precursor cells (15) . Subsequently, the endocrine precursor cells differentiate toward mature hormone-producing endocrine cells that are classified into at least 15 different terminally differentiated subsets according to their specific hormone expression (1, 25) . Although the molecular mechanisms that regulate enteroendocrine cell differentiation have not been fully characterized, recent molecular and transgenic studies have identified key transcription factors implicated in this process (27) . Those transcription factors include Pax4 (17) , Pax6 (17) , BETA2/NeuorD (21), Pdx1 (32) , Gfi (29), Nkx2.2 (8) and Sox9 (9) .
Less complicated but similar to the central nervous system, there is a unique relationship between spatial orientation of the enteroendocrine cells and their differentiation process (1, 4, 25) . Previous reports on the characterization of enteroendocrine cell differentiation using 5-bromo-2-deoxyuridine (BrdU) incorporation and morphological and immunohistochemical methods demonstrated that the majority of enteroendocrine cells complete the differentiation process within the crypt and migrate upward along the villus as mature hormone-producing cells (1, 25) . However, a small population of enteroendocrine cells migrates downward to the bottom of the crypt. This population was first found and described in 1981 by Bjerkness and Cheng (5) . Later, it was reported that a subset of coexpressing substance P and serotonin remain in the crypt while a subset of endocrine cells involving sequential expression of substance P, serotonin, and secretin migrates out of the crypts into the villi (1). Moreover, Formeister et al. (9) have recently demonstrated highly Sox9-expressing cells residing below position ϩ4 that coexpress chromogranin A (ChgA) and/or substance P. Therefore, it seems that enteroendocrine cells are comprised of subsets whose differentiation is determined by specific transcription factors that regulate both the specific coexpression of hormones and associated location within the crypt-villus axis. The differentiation signaling pathways mediated by Wnt, Hedgehog, Notch, bone morphogenetic protein (BMP), and EphB/ephrin are restricted spatially along the crypt-villus axis in the epithelium and the mesenchyme of the intestine (7) . Below position ϩ4 in the crypt, there is an especially Wnt-signaling active zone where the self-renewing Lgr5ϩ stem cells reside with Paneth cells. Presently, it is unclear what determines whether a subset of enteroendocrine cells re-mains in the Wnt signaling-rich area instead of migrating up to the villus and why. At least in this aspect, the nature of the enteroendocrine cell population that resides at the crypt base remains uncharacterized.
This subset of enteroendocrine cells that resides at the crypt base has become our particular interest especially because we are able to visualize green fluorescent protein (GFP)ϩ enteroendocrine cells at the crypt base in the genetically engineered animals that express GFP under the control of the cholecystokinin (CCK) gene promoter. In addition, the technique recently developed to make cultured organoids enables us to trace migration patterns of GFP-expressing endocrine cells along the crypt-villus axis. In this study, by taking advantage of GFP expression, we examined CCK-GFP-expressing cells for expression of differentiation markers and migration patterns in freshly isolated primary crypts and cultured organoid system, respectively, to characterize the subset at the crypt base using the CCK transgenic animals. Here we demonstrate that the subset of endocrine cells at the crypt base resides in this Wnt signaling-active zone after its downward migration from around position ϩ4 and expresses both stem and postmitotic mature endocrine cell markers and that this subset is at least phenotypically different from other subsets of enteroendocrine cells that migrate upward to the villus.
MATERIALS AND METHODS
Mice. Transgenic mice with CCK promoter-driven enhanced GFP (eGFP) were developed by the GenSat Bacterial Artificial Chromosomes Transgenic project (12) tm1(CRE/ER2T)cle /J; stock no. 008875] were obtained from the Jackson Laboratory (Bar Harbor, ME). All procedures involving mice followed National Institutes of Health guidelines and were approved by the NIDDK Animal Care and Use Committee.
Crypt preparation and immunohistochemistry. Crypt-enriched preparations were obtained from the proximal 5-6 cm of duodenum by incubation in Dulbecco's PBS (DPBS) containing 2 mM EDTA for 30 min at 4°C followed by vigorous pipetting. The crypt-enriched materials were fixed in 4% paraformaldehyde in DPBS for 1 h at room temperature and treated with DPBS containing 0.1% Triton X-100 for 30 min. Crypts were immunostained with primary antibody at 4°C overnight in DPBS containing 1% bovine serum albumin. The primary antibodies used were as follows: 1:100 rabbit anti-CD133 (ab19898; Abcam, Cambridge, MA), 1:100 rabbit anti-Lgr5 (ab75850, Abcam), 1:50 rabbit anti-doublecortin and CaM kinase-like-1(DCAMKL1) (ab37994, Abcam), 1:50 rabbit anti-neurogenin 3 (ab76686, Abcam), 1:100 rabbit anti-Ki-67 (ab15580, Abcam), 1:200 Alexa 647-conjugated antiphospho-Histone H3 (no. 3458; Cell Signaling, Danvers, MA), and 1:2,000 rabbit anti-Chg A (no. 20085; ImmunoStar, Hudson, WI). Rabbit anti-ghrelin (a gift from Dr. Yuxiang Sun) (31) and mouse monoclonal anti-CCK antibodies (MAb9303; Cure Antibody Lab, UCLA) were used after 1:1,000 and 1:5,000 dilution to detect ghrelin and CCK, respectively. For detection of Ki-67, antigen retrieval was achieved by incubating the crypt-enriched samples with PBS containing 1% SDS for 5 min at room temperature. After incubation with primary antibody, cryptenriched samples were incubated with either Alexa Fluor 633-conjugated goat anti-rabbit IgG secondary antibody or Alexa Fluor 597-conjugated goat anti-mouse IgG secondary antibody (Invitrogen, Carlsbad, CA). Immunostained crypts were subjected to confocal as well as bright-field examination with a complete Z-stack using a Zeiss LSM510 Meta confocal microscope (Carl Zeiss, Thornwood, NY). The confocal fluorescence and the bright-field images were merged and analyzed using LSM510 Meta software. This method allowed us to clearly identify and locate Paneth cells, which served as visible landmarks in all the depths, and thus to determine the position of GFPϩ cells systemically as previously described (2) . Specificity of immunoreactivity was assessed using appropriate control IgG (Genscript, Scotch Plains, NJ).
Preparation and culture of the organoids. Preparation and culture of the organoids were performed as previously reported (26) . Briefly, crypts were separated from murine duodenum by incubation in DPBS containing 2 mM EDTA for 30 min at 4°C followed by vigorous pipetting. After crypts were counted, a total of 100 -500 crypts was mixed with 50 l of Matrigel (no. 354230; BD Bioscience, San Jose, CA) and plated in 24-well plates. After polymerization of Matrigel, the crypts in Matrigel were merged and cultured in 500 l of Advanced DMEM/F12 (Invitrogen) containing growth factors, 50 ng/ml epidermal growth factor (no. 315-09; Peprotech, Rocky Hill, NJ), 500 ng/ml R-spondin 1 (no. 3474-RS; R&D, Minneapolis, MN), and 100 ng/ml Noggin (no. 250 -38, Peprotech). Growth of the organoids was maintained by adding the growth factors every 2-3 days. For passage, the growing organoids were mechanically dissociated into single-crypt domains by gentle pipetting and then transferred to fresh Matrigel with 1:5 split ratio every 1-2 wk.
Monitoring GFPϩ cells in the live organoids. We recorded position and movement of GFPϩ cells in the live organoids using a conventional (nonconfocal) epifluorescence microscope (Nikon, Tokyo, Japan). This nonconfocal approach was used to minimize the false determination of the appearance or disappearance of GFP caused mainly by changes in position and size of crypts during the growth of crypts and organoids and also to observe GFPϩ cells throughout a whole organoid. Multiple images taken at different focal planes (depth of field) were acquired using NIS-elements F2.20 software (Nikon). We then performed postimaging analysis by examining on-site records and multiple images. The organoid cultures were examined periodically within an 8 -16-h interval over 120 h. The cultures were maintained in the incubator during the interval.
Immunohistochemistry of organoids. The organoids were first freed from Matrigel by dispase treatment and several washes with PBS in a 24-well plate. The free-floating organoids were then fixed in 4% paraformaldehyde in DPBS for 1 h at room temperature and treated with DPBS containing 0.1% Triton X-100 for 30 min. The organoids were immunostained with the primary antibodies to DCAMKL1 and ChgA at 4°C overnight in DPBS containing 1% bovine serum albumin and then with Alexa Fluor 633-conjugated goat anti-rabbit IgG secondary antibody. Immunostained organoids were gently mounted on the slide glass and observed under the Zeiss LSM510 Meta confocal microscope.
RESULTS

Locations and numbers of GFPϩ cells in the duodenal crypts of CCK-GFP transgenic mice.
CCK-GFP expressing cells in the primary crypt preparations from CCK-GFP transgenic mice were clearly identifiable by either epifluorescence or confocal microscopy. For the accurate acquisition of position and number of GFPϩ cells that were positioned at different depths, we used confocal microscopic analysis and scanned each crypt along the z-axis and acquired a Z-stack of multiple images with a 1-m interval (Fig. 1A) . The results from this analysis indicated that an average number of GFPϩ cells per crypt in CCK-GFP mice was 1.04 ( Fig. 1B) and that the GFPϩ cells were positioned not only in the upper crypt but also at the crypt base (Fig. 1C) . The confocal analysis of the location of GFPϩ cells indicated that the CCK-GFPϩ cells were most frequently found at positions 2=, 4=, and above position 10 ( Fig. 1C) .
Phenotypic characterization of GFPϩ cells in the duodenal crypts of CCK-GFP transgenic mice.
To study the correlation between location and differentiation of the GFPϩ cells in the primary duodenal crypts from CCK-GFP transgenic mice, we performed immunohistochemistry for phenotypic expression of markers of differentiation. The phenotypic markers used for this study were putative intestinal stem cell markers Lgr5, CD133, and DCAMKL1, neuroendocrine transcription factor Ngn3, mature neuroendocrine marker ChgA, and CCK. In the primary duodenal crypts from CCK-GFP transgenic mice, expression of stem cell markers Lgr5 and DCAMKL1 were prominent in the majority of the CCK-GFPϩ cells below position ϩ4 (Figs. 2 and 3 ). The expression of CD133 in the GFPϩ cells was less restricted compared with the expression of Lgr5 and DCAMKL1 and therefore found also above position ϩ4. Ngn3 expression was cytoplasmic and nuclear, rather frequent in the GFPϩ cells located below position ϩ4, and decreased sharply toward the crypt-villus border. ChgA was positive for the majority of the GFPϩ cells throughout the crypt, indicating that the GFPϩ cells located below position ϩ4 belong to the endocrine cell lineage. Consistent with this finding, no expression of goblet cell marker mucin 2, Paneth cell marker lysozyme, or enterocyte marker CD13 (16) S2 ) while ghrelin peptide was negative. These results validated the faithful and specific expression of GFP in CCK-expressing cells in the CCK-GFP mice. Interestingly, CCK and ghrelin were both immunopositive in the majority of CCK-GFP cells located below position ϩ4, suggesting that these peptides were coexpressed in the GFPϩ cells positioned below ϩ4 (Figs. 2  and 3 ). To examine the expression status of other hormones, we also checked for the expression of secretin and glucosedependent insulinotropic polypeptide (GIP) in the primary duodenal crypts from CCK-GFP mice and found that secretin and GIP were expressed in 40% and over 80% of the GFPϩ cells positioned at the crypt base, respectively (Supplemental Figs. S3 and S4). We then stained the crypts with Ki-67 and phospho-Histone H3 to examine proliferative activity of the GFPϩ cells and found that the GFPϩ cells in the crypts were negative for both Ki-67 and phospho-Histone H3 and therefore were at a postmitotic stage in CCK-GFP mice (Fig. 4) . These results from the primary crypts suggest that there are at least two distinct subsets of GFPϩ cells that are committed to the endocrine cell lineage: 1) mature CCK-producing cells, which migrate to the villus and 2) stem markerϩ endocrine cells, which reside with intestinal stem cells and Paneth cells at the crypt base. However, the latter subset of GFPϩ cells were neither undifferentiated stem nor transient amplifying precursor cells because they were negative for both Ki-67 and phospho-Histone H3 and expressed CCK as well as ChgA (Figs. 2-4) . Furthermore, these crypt-based GFPϩ cells lost their specific expression of CCK and expressed multiple peptide hormones that may suggest a less differentiated, intermediate state of development. Therefore, the CCK-GFPϩ cells at the crypt base possess phenotypes of both stem and postmitotic endocrine cells.
ChgA immunostaining of GFPϩ cells in the duodenal crypts of Lgr5-GFP transgenic mice.
To validate Lgr5 expression in the enteroendocrine cells at the crypt base, we performed a counter experiment using Lgr5-GFP transgenic mice. As demonstrated by Barker et al. (2) , Lgr5-GFP cells were found mostly around Paneth cells at the crypt base in primary duodenal crypts freshly isolated from Lgr5-GFP transgenic mice. A whole-mount immunostaining of the crypts for CCK demonstrated CCK immunoreactivity in Lgr5-GFP-positive The data for each marker were obtained from 50 -80 crypts. NA, not applicable because no GFPϩ cell was identified at the position in the preparation. P, positive, but the proportion bar was not displayed because n was Ͻ2. Lgr5, leucine-rich repeat-containing G protein-coupled receptor 5; DCAMKL1, doublecortin and CaM kinase-like-1; Ngn3, neurogenin 3; ChgA, chromogranin A; Ghln, ghrelin. cells at the crypt base (Fig. 5A) . Similarly, the ChgA staining also showed immunoreactivity in Lgr5-GFP-positive cells at the crypt base (Fig. 5B ) that was restricted mainly to positions 1= and 2= (Fig. 5C ). This result was consistent with the Lgr5 immunohistochemical data obtained in CCK-GFP mice.
Tracking GFPϩ cells in the organoids established from CCK-GFP transgenic mice. To study spatial and temporal dynamics of CCK-GFP cells and further understand the relationship between the positions of the GFPϩ cells and their phenotypic expression observed in the primary crypts, we established an ex vivo organoid system from CCK-GFP transgenic mice (26) . The organoids grew in Matrigel in the presence of epidermal growth factor, R-spondin, and Noggin. The morphology and the time course of the growth of CCK-GFP organoids were similar to those reported for organoids from Lgr5-GFP mice (26) . The average number of CCK-GFPϩ cells per crypt was between 1 and 1.5. The CCK-GFPϩ cells were scattered throughout the organoid in both villus regions and crypts and frequently found beside Paneth cells around the crypt base area (Fig. 6) . Thus the numbers and positions of the GFPϩ cells in the organoids were quite similar to those in primary crypt preparations. To determine phenotypic expression of the GFPϩ cells that were beside Paneth cells at the crypt base area, we performed whole-mount immunostaining. Consistent with the results from the primary crypts, the immunostaining indicated that the GFPϩ cells at the crypt base area were positive for the stem cell marker DCAMKL1 and the mature enteroendocrine marker ChgA (Fig. 6C) .
To monitor position, movement and growth of the GFPϩ cells, we used CCK-GFP organoids and acquired multiple images from five organoids periodically with an 8 -16-h interval over 120 h using epifluorescence microscopy. From this time-course experiment, we were able to confidently track a total of 40 CCK-GFPϩ cells residing in 17 crypts (Fig. 7) . At the initiation of the recording, 20 GFPϩ cells were already present in 17 crypts (1.18 cells per crypt). During the 120-h observation period, 20 GFPϩ cells appeared de novo, mostly in position ϩ4. Out of 40 GFPϩ cells, 19 GFPϩ cells (47.5%) moved up to the villus while four GFPϩ cells (10%) moved downward. Sixteen GFPϩ cells (40%) remained in the same region. Only one GFPϩ cell disappeared from the crypt base. However, no GFPϩ cells migrated out from the crypt base once they positioned in the area. These results are summarized schematically in Fig. 7 and a series of images from two representative crypts demonstrating de novo appearance of GFPϩ cells around position ϩ4 as well as bidirectional migration (Figs. 8 and 9 ). 
DISCUSSION
Although the majority of the enteroendocrine cells differentiates and migrates up to the villus to function, a small population of enteroendocrine cells migrates down to the bottom of the crypt. This population was first found and described in 1981 by Bjerkness and Cheng (5). In the primary duodenal crypts from CCK-GFP transgenic mice, the GFPϩ enteroendocrine cells were found not only in the upper crypt but also in the crypt base. The study of the location of the GFPϩ cells and their frequency indicated that 20% of the GFPϩ cells in the crypt were positioned at the crypt base below position ϩ4. Therefore it is possible that the GFPϩ enteroendocrine cells at the crypt base were the downwardly migrating population that was previously reported by Bjerkness and Cheng (5). However, since the intestinal stem cells reside below position ϩ4 in the crypt, it was also reasonable to hypothesize that the GFPϩ cells were the intestinal stem cells and that they exhibited low basal level of GFP expression because the stem cells might possess low-level but broad transcriptional activity including peptide hormone expression represented by the GFP marker.
To see whether the GFPϩ cells positioned in this domain were stem cells, we examined expression of three presently known putative intestinal stem cell markers, Lgr5, DCAMKL1, and CD133. A previous Cre-mediated lineage tracing study has shown that LacZ expression triggered by the Lgr5 gene promoter produced continuous LacZ-positive blue ribbons of cells from the crypt base to the tips of villi (2) . The lineage tracing also showed that all four cell types of the intestinal epithelium, enterocyte, Paneth cells, goblet, and enteroendocrine cells, were contained in the LacZ-blue ribbons, suggesting that Lgr5ϩ cells represent a cycling multi-potent stem cell population (2) . In addition, a single Lgr5ϩ stem cell was found to be capable of forming a long-lived, self-renewing gut organoid in culture (26) . Therefore Lgr5 has been recently considered to serve as a marker for the selfrenewing stem cells of the intestinal epithelium. Although there is a report that DCAMKL1 is also expressed in Tuft cells (11) , it has also been reported to be expressed in the lower two-thirds of the crypt and predominantly in the cells at position ϩ4, where a quiescent stem cell has been suggested to reside (20) . DCAMKL1 cells retained BrdU and were capable of producing gut epithelial lineages in athymic nude mice after transplantation of the formed spheroids (20) . CD133/Prominin-1 has served as a putative stem cell marker in both normal and malignant tissues in many organs including the intestine (33) . Although the expression of CD133 is not totally restricted to stem cells but rather broad, CD133 has been frequently used to identify the stem cell population in the intestine. The results from the present immunohistochemical study showed that many of those GFPϩ cells below position ϩ4 were positive for all these putative stem cell markers Lgr5, DCAMKL1, and CD133. Lgr5 expression was restricted the most to the crypt base region, whereas the expression of CD133 was found not only in the crypt base but also in many GFPϩ cells that migrated above position 10. Expression of DCAMKL1 was highly frequent in the GFPϩ cells located below position ϩ4 but absent in the GFPϩ cells that were above position 10. Thus the expression patterns of these three markers in the primary crypt were also consistent with those reported previously by others (2, 20, 30) except that cytoplasmic rather than apical membrane staining of CD133 was observed frequently at the crypt base in this study (Supplemental Fig. S6 ). These clear and conclusive results suggest that many of the GFPϩ cells at the crypt base were intestinal stem cells. However, this is apparently contrary to the previously reported population of morphologically recognized enteroendocrine cells that migrates down from position ϩ4 to the crypt base (5) .
To further characterize the GFPϩ cells located below position ϩ4, we examined expression of enteroendocrine markers representative of different stages of development. These markers primarily included Ngn3, ChgA, and CCK. Ngn3 is a proendocrine bHLH transcription factor required for enteroendocrine cell differentiation (14, 18) . Expression of Ngn3 is temporally induced by inactivation of Notch signaling and switched off before cells are terminally differentiated. Thus Ngn3 marks early precursor cells of endocrine fate and endocrine cells at an early stage in their differentiation (4, 28) . In contrast, ChgA, a secretory protein that functions in formation of secretory granules and regulation of secretion, can serve as a differentiated mature panenteroendocrine marker (6, 22) . In agreement with the previously reported observation (4), in the primary duodenal crypts, the CCK-GFPϩ cells above position 10 were almost all negative for Ngn3 immunostaining, whereas the majority of the GFPϩ cells located below position ϩ4 were positive. Because this result further suggests that the CCK-GFPϩ cells located below position ϩ4 were intestinal stem cells or early precursor cells that were positive for stem cell markers, we predicted that the CCK-GFPϩ cells positioned below position ϩ4 should be negative for ChgA expression. However, contrary to our prediction, ChgA was expressed not only in the GFPϩ cells located in the upper crypt but also in the GFP cells located below position ϩ4. Therefore, these findings are inconsistent with the present knowledge regarding the differentiation of enteroendocrine cells. This apparent contradiction was also validated by a counter experiment using Lgr5-GFP transgenic mice (Fig. 5) . Thus we identified strong ChgA as well as CCK immunoreactivity among the Lgr5-GFPϩ cells positioned at the crypt base (Fig. 5, A and B) . We also confirmed that Lgr5-GFP expression in ChgA-positive cell population in the crypts was restricted mainly in the area below position ϩ4 (Fig. 5C) . Therefore, these results were consistent with the results of Lgr5 immunoreactivity in the CCK-GFP transgenic model. Furthermore, in addition to the ChgA and CCK immunoreactivity, over 80% of the CCK-GFPϩ cells below 4 also coexpressed ghrelin. This result was surprising because CCK-and ghrelin-producing cells were relatively far apart in terms of enteroendocrine cell types because of their different dependence on Ngn3 and Nkx2.2. Neither Ngn3 nor Nkx2.2 seemed to be required for differentiation into ghrelinexpressing cells, whereas both are apparently essential for differentiation into CCK-producing cells (8, 14, 18) . Because CCK and ghrelin immunoreactivity were exclusive of each other in the GFPϩ cells positioned in the upper portion of the crypt and also in the villi (Supplemental Fig. S2 ), specificity of these antibodies was apparently well preserved. To understand the expression status of other hormones, we also checked for the expression of secretin and GIP in the primary duodenal crypts from CCK-GFP mice. Consistent with the previous observations (1, 21) , the expression of secretin was accompanied frequently with the CCK-GFP, whereas GIP expression was dissociated from CCK in the upper portion of the crypt and in the villi. In contrast, secretin and GIP were expressed in 40% and over 80% of the GFPϩ cells positioned at the crypt base, respectively (Supplemental Figs. S3 and S4) . These results suggest further that the GFPϩ endocrine cells at the crypt base were capable of expressing multiple endocrine hormones at least at immunohistochemically detectable levels. Finally, staining results for Ki-67 and phospho-Histone H3 indicated that the GFPϩ cells in the crypts were all postmitotic (lacking both Ki-67 and phospho-Histone H3 labeling) (Fig. 4) . Therefore, overall results from the primary crypt studies indicate that the GFPϩ enteroendocrine cells at the crypt base possess phenotypes of both stem and postmitotic endocrine cells and are distinct from the majority of the GFPϩ endocrine cells that differentiate to mature CCK-producing cells and migrate up to the villus.
The organoid system established from the CCK-GFP transgenic mice provided us convenient tools to trace temporal and spatial fates of GFPϩ enteroendocrine cells. We determined that temporal and spatial patterns of GFPϩ cells were reliably mimicking the in vivo status because the numbers and positions of the GFPϩ cells in the crypts of the organoids were quite similar to those in the primary crypts. Thus the organoid maintained an average number of GFPϩ cells per crypt between 1 and 1.5. In the primary crypts, an average number of GFPϩ cells per crypt in CCK-GFP was 1.04. As expected, the tracking of GFPϩ cells indicated the upward migration of many GFPϩ cells to the villus domain. As seen in the primary crypts, there were also the GFPϩ cells beside Paneth cells at the crypt base in the organoids. These GFPϩ cells at the crypt base showed expression of stem cell markers DCAMKL1 and ChgA (Fig. 6) . Therefore, as in the primary crypts, organoids also contain GFPϩ cells that possess phenotypes of both stem and endocrine cells at the crypt base. By tracking GFPϩ cells in the organoids, we could determine the origin of those GFPϩ cells at the crypt base. Although determining the exact origin of the GFPϩ cells was difficult, it was clear that no GFPϩ cell arose de novo from the base of the crypt. It was also clear that most of the de novo GFPϩ cells appeared near position ϩ4, which was located at an 80 -120-degree angle from the tip of the crypt base. As demonstrated in Figs. 6, 7, and 8, we have succeeded in tracking the GFPϩ cells that appeared near position ϩ4 and migrated down to the crypt base. Importantly, no GFPϩ cells left the crypt base once they reached the base except one GFPϩ cell at the crypt base disappeared on site possibly by apoptosis or loss of promoter activity. In summary, we observed that a population of GFPϩ cells originated near position ϩ4, migrated down, stayed at the crypt base beside Paneth cells, and never left the base of the crypt. Therefore, the crypt base is the final destination for the subset of the GFPϩ cells that migrates downward. This subset is positive for stem cell markers, mature endocrine markers, and multiple hormones (Fig. 10) .
In the GFP-tracking experiment, it was evident that the migration of GFPϩ enteroendocrine cells was bidirectional with a population of GFPϩ cells migrating down to the crypt base as previously described (5) . It has been reported that this segregation is controlled by Wnt signaling through the expression of ephrin and its receptors EphB2 and EphB3 (3, 13) . In the intestine, activation of Wnt turns on the expression of EphB2 and EphB3 and confines the cells expressing those receptors to the crypt base (3, 13). Lgr5ϩ cells sorted on the basis of Lgr5-eGFPϩ intensity showed selectively higher expression of EphB3 than EphB2 (30) . Consistent with those findings, we found that there was a gradient of EphB3 expression among the GFPϩ cells along the crypt-villus axis and was highest at the crypt base as previously reported ( Supplementary  Fig. S5) (3) . Therefore, this result suggests that EphB3 is responsible at least in part for the segregation of the population of GFPϩ cells that migrates down to the crypt base.
In conclusion, overall our findings indicate the presence of a distinct subset of enteroendocrine cells that are stem cell markerϩ, ChgAϩ, and able to coexpress multiple endocrine hormones. This subset appears near position ϩ4 and migrates downward to reside at the crypt base. To our knowledge, neither the phenotypic nature nor function of this population is known. It is also unknown whether this subset of enteroendocrine cells is terminally differentiated and thus destined to apoptosis or arises from a postmitotic, multipotent precursor cell that is a direct descendant of stem cells rather than from a The observed correlation between the positions and expression of phenotypic markers in the primary crypts indicated that a subset that migrates upward differentiates into a mature CCK-producing cells and that a subset that migrates downward expresses undifferentiated stem cell markers in addition to enteroendocrine markers and multiple neuropeptides. GIP, glucose-dependent insulinotropic polypeptide.
proliferating transit amplifying population. It is also unknown whether it cycles back to stem or precursor stage. Thus further investigations such as gene expression in the subset, lineagebased tracking, and ultrastructural analysis are needed to answer these questions. Because of their close location to the intestinal stem cells, it is not unreasonable to hypothesize that these cells are not simply functioning just as a hormone releaser but playing some role in stem cell biology that is related to the generation and regulation of enteroendocrine cell lineage. Moreover, the present findings may also have an implication for the tumorigenesis of enteroendocrine cells because stem cell marker ϩ cells are suggested to be susceptible to neoplastic transformation (33) and also because the subset is continuously exposed to Wnt signaling. Therefore, further investigation of this subset may provide novel insights into the genesis and differentiation of enteroendocrine cells as well as of enteroendocrine tumorigenesis.
